Go Pro
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

CV Sciences logo
$0.03 +0.01 (+36.32%)
As of 03:56 PM Eastern

About CV Sciences Stock (OTCMKTS:CVSI)

Advanced

Key Stats

Today's Range
$0.02
$0.03
50-Day Range
$0.02
$0.03
52-Week Range
$0.02
$0.10
Volume
385,888 shs
Average Volume
606,930 shs
Market Capitalization
$5.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CV Sciences, Inc. is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation. The company sells its branded products through e-commerce channels, specialty retailers, pharmacies and major retail chains, and it holds regulatory registrations and quality certifications designed to meet evolving standards for hemp-derived products in domestic and select international markets.

Since its incorporation in Delaware in 2012, CV Sciences has expanded its geographic reach to serve customers across North America, Europe and parts of Asia, with strategic partnerships aimed at broadening distribution and ensuring supply-chain integrity. The company emphasizes scientific research, quality control and regulatory compliance, maintaining laboratory testing protocols for potency and purity at multiple stages of production.

CV Sciences is guided by a management team with experience in nutraceuticals, regulatory affairs and consumer-goods marketing. The company continues to invest in product innovation, clinical research collaborations and brand development as it seeks to strengthen its position in the growing hemp-derived CBD market.

AI Generated. May Contain Errors.

CV Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

CVSI MarketRank™: 

CV Sciences scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CV Sciences.

  • Price to Book Value per Share Ratio

    CV Sciences has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently decreased by 95.96%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CV Sciences does not currently pay a dividend.

  • Dividend Growth

    CV Sciences does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for CV Sciences this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, CV Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    6.70% of the stock of CV Sciences is held by insiders.

  • Percentage Held by Institutions

    CV Sciences has minimal institutional ownership at this time.

  • Read more about CV Sciences' insider trading history.
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CVSI Stock News Headlines

“Made in the United States” could mean something new
Investment expert Alexander Green believes a new AI technology could amplify efforts to bring manufacturing, energy, and jobs back to the United States. He has identified six stocks positioned around this shift, spanning manufacturing, AI, and energy infrastructure. Bill O'Reilly recently sat down with Green to discuss why Trump's second term could outpace his first. The full story appears in a free video, The Return of the American Dream.tc pixel
See More Headlines

CVSI Stock Analysis - Frequently Asked Questions

CV Sciences' stock was trading at $0.0614 at the beginning of the year. Since then, CVSI shares have decreased by 57.8% and is now trading at $0.0259.

CV Sciences, Inc. (OTCMKTS:CVSI) announced its quarterly earnings results on Thursday, August, 12th. The company reported ($0.03) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.03). The business had revenue of $5.13 million for the quarter, compared to analysts' expectations of $5.12 million. CV Sciences had a negative trailing twelve-month return on equity of 94.61% and a negative net margin of 11.15%.

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Cronos Group (CRON), Kushco (KSHB), NVIDIA (NVDA) and Organigram Global (OGI).

Company Calendar

Last Earnings
8/12/2021
Today
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
CIK
1510964
Employees
70
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$960 thousand
Net Margins
-11.15%
Pretax Margin
-11.14%
Return on Equity
-94.61%
Return on Assets
-20.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.96
Quick Ratio
0.21

Sales & Book Value

Annual Sales
$13.79 million
Price / Sales
0.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
2.59

Miscellaneous

Outstanding Shares
203,980,000
Free Float
190,311,000
Market Cap
$5.28 million
Optionable
Not Optionable
Beta
0.47

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:CVSI) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners